Continuous SEC was shown to increase productivity with the same product quality and yield.
Martin Glenz
Advertisement
Martin Glenz is principal scientist at Pall GmbH.
Articles by Martin Glenz
Advertisement
Latest Updated Articles
Continuous Preparative SEC for Purification of “Difficult-to-Manufacture” Proteins–A Feasibility StudyPublished: November 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
